D-Wave’s stagnant revenue, escalating costs, and uncertain commercial adoption point to a business that was always meant for Wall Street, not selling quantum compute.  When D-Wave reports its Q3 results in November, it will signal the end of their investment thesis. We’ve already seen all the evidence for a year about why their commercial case

What Happened Rigetti Computing and Purdue University published research, showing how a quantum processor can speed up the software companies already use to solve optimization problems. Unlike other promises in the optimization spaces, the quantum part doesn’t solve the problem. But it does feed useful information into classical solvers, which already exist in the enterprise

In May 2026, the US Department of Commerce announced roughly $2 billion in planned CHIPS and Science Act funding for the quantum computing industry, spread across nine companies. On September 8, it converted most of that into real contracts. D-Wave Quantum, Rigetti Computing, Quantinuum, PsiQuantum, and GlobalFoundries each signed a definitive agreement for up to

Quantinuum (QNT) posted its first quarter as a public company on Tuesday evening, and it’s clear that both the technology and commercial traction are moving in the same direction. Q2 revenue was up almost 3x, they raised full-year guidance on the way out of the IPO gate, and confirmed a named system sale to Oracle.

In late July, investor interest surged with news that AT&T would expand its use of D-Wave’s quantum annealing technology “across network operations”. There were claims about success, speedup, etc. but investors need to understand what the project actually was.

D-Wave and Japan Tobacco published a peer-reviewed paper in Scientific Reports on July 9 describing quantum-assisted molecular design.